139 - Factors that complicate pharmacokinetics Flashcards

1
Q

Zero order pharmacokinetics

A

Excreted at a constant rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Effect of low bioavailability

A

If low, then variability will have a greater effect. Need to administer via different routes, EG nicotine patches, gaseous general anaesthetics, insufflation, rectal.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Types of unusual drug behaviour 1 2 3

A

• bioavailability is low – if low, more sensitive to variability • slow distribution – some drug eliminated during distribution • drug in sufficiently high concentration to saturate elimination process(es) – elimination rate is constant (zero order kinetics)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Rationale behind alternative administration routes for drugs with low bioavailability

A

Bypass first-pass hepatic metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Drug reservoirs

A

Sites in the body where drug accumulates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Possible effects of drug reservoirs

A

• can prolong action – released from store as concentration falls • can quickly terminate action – if stored drug has high capacity • can lead to slow distribution – if capacity of store is great

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Examples of drug reservoirs 1 2 3

A

• Plasma proteins • Cells • Fat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Plasma protein drug reservoirs 1 2 3

A

– only unbound drug gets from plasma to tissues –may get displacement from similar drugs – eg. aspirin can displace warfarin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Cellular drug reservoirs 1 2

A

– accumulation due to active transport or specific binding – eg. antimalarial quinacrine highly concentrated in liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Fat drug reservoirs 1 2

A

– highly lipid-soluble drugs – blood supply is poor and capacity large, so may lead to slow distribution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Rapid iv administration of slow-distributing drug 1 2 3 4

A

1) Drug rapidly distributes to central compartment (well-perfused organs) 2) Slowly distributes to peripheral organ (where it is stored in a reservoir, EG in fat, muscle) 3) Distribution equilibrium is established, according to volume of distribution 4) Elimination occurs from central compartment (blood, kidneys, liver), changing equilibrium, pulling drug out of reservoir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

*Rapid iv administration of slow-distributing drug

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Effect of peak concentration in blood if a drug is absorbed quickly into a reservoir versus if it is absorbed slowly

A

Slowly-absorbed drugs have a higher initial concentration in blood (slowly-absorbed is initially confined to central compartment)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

When is it a problem for a drug to be distributed slowly to reservoir?

A

If the drug has a narrow therapeutic window, as peak concentration can exceed maximum limit of therapeutic window

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Example of a slowly-distributing drug

A

Digoxin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Calculation of peak concentration of a slowly-distributing drug from Vd at equilibrium

A

– peak concentration is higher than predicted from Vd (at equilibrium)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Digoxin administration 1 2 3 4

A

– Slowly distributes into reservoirs – Narrow therapeutic index – Long half life so requires loading dose – Loading dose must be divided to avoid toxic peak concentration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Type of drugs that normally display zero-order elimination

A

Those that are administered in high concentrations (elimination is saturated)

19
Q

*Zero-order elimination of drugs

A
20
Q

When do drugs with zero-order kinetics become problematic? 1 2 3

A

1) When multiple dosings are required. 2) Steady state is never reached, concentration just increases as elimination rate is constant. 3) Changing dose rate can disproportionately increase rate of concentration increase

21
Q

Examples of drugs with zero-order elimination

A

Aspirin Phenytoin

22
Q

Phenytoin 1 2 3

A

1) Anti-epileptic drug, anticonvulsant. 2) Zero-order kinetics. 3) Taken over long periods, any changes to dose rate gives big changes in drug concentration, so need to monitor dosing regime very carefully (EG take regular blood samples to monitor blood concentrations)

23
Q

Things that can cause interpatient variability with pharmacokinetics

A

• Age • Genetic factors • Idiosyncratic reactions • Disease • Drug-drug interactions

24
Q

Effects of age on kinetics 1 2 3

A

Relates to • Renal excretion • Hepatic metabolism Reduced in • Neonates • Elderly Leads to increased half life of some drugs • May require reduced dose if multiple dosing

25
Q

Renal clearance of newborns

A

~renal clearance rate is 20% of that of an adult

26
Q

Effect of premature birth on renal clearance rate

A

Lowers renal clearance rate

27
Q

How long does it take for newborn renal clearance rate to reach adult levels?

A

~1 week

28
Q

When does renal function begin decreasing?

A

Age 20

29
Q

Renal function at 50yo

A

~75%

30
Q

Problem with renal function decreasing with age

A

Issue for drugs administered over years, EG digoxin

31
Q

Issue with newborn drug metabolism 1 2 3

A

• Deficient in some drug metabolising enzymes (particularly phase II conjugation) • 6 weeks to reach adult levels • Increased plasma half life – eg. chloramphenicol, morphine

32
Q

Metabolism in the early 1 2

A

• Reduced activity of cytochrome p450 • Increased half life – eg. diazepam

33
Q

Why can’t morphine be given to a pregnant woman?

A

Babies can’t metabolise morphine initially (is metabolised with phase II conjugation, which babies can’t do). Baby has a dose of morphine that it can’t metabolise.

34
Q

Pharmacodynamic drug-drug interactions

A

• Drug A modifies effect of drug B without affecting its concentration

35
Q

Pharmacokinetic drug-drug interactions

A

• Drug A modifies concentration of drug B at its receptor

36
Q

When are drug-drug interactions clinically important? 1 2

A

• Affected drug must have narrow therapeutic index – small reduction in concentration will lead to loss of effect – small increase in concentration will lead to toxicity • Concentration-response curve to affected drug should be steep – small change in concentration gives large change in effect

37
Q

Ways in which pharmacodynamic drug-drug interactions can come about 1 2

A

1) Receptor antagonism 2) Physiological effects

38
Q

Ways in which pharmacokinetic drug-drug interactions can come about

A

Can affect • absorption • distribution • metabolism • excretion

39
Q

In drug-drug interactions, how can absorption be affected? 1 2

A

• Gastric emptying rate – decreased by opiates – increased by metoclopramide • Formation of poorly-absorbed complex in gut – calcium (EG from milk) and tetracyclines

40
Q

In drug-drug interactions, how can distribution be affected? 1 2

A

Displacement from plasma protein binding sites • Transient increase in free (unbound) drug – Transient toxicity • Increased elimination to give reduced total drug but similar free drug prior to displacement – Altering of target therapeutic range

41
Q

Example of plasma-protein displacement in drug-drug interactions 1 2 3

A

Aspirin displacing phenytoin • Normally measure total phenytoin in plasma • Aspirin will reduce total phenytoin, but leave free phenytoin unchanged • Tempting to erroneously increase dose of phenytoin – toxicity

42
Q

Example of drug-drug interactions altering drug metabolism 1 2 3

A

Induction of cytochrome p450 system by eg. • Rifampicin • Ethanol Leads to • Reduced half life/reduced concentration in plasma – eg. Warfarin • Increased bioactivation leading to increased toxicity – eg. Paracetamol

43
Q

Examples of drugs that can inhibit cytochrome p450

A

Steroids, cimetidine. Causes problems with drugs that have a narrow therapeutic window, are metabolised by CYP450 (EG digoxin, phenytoin)

44
Q

Examples of how drug-drug interactions can affect drug excretion in urine 1 2 3

A

• Protein binding – Affects filtration • Tubular secretion – Probenecid as a banned substance in sport • Urine flow/pH – Sodium bicarbonate in treatment of aspirin overdose